Intranasal Dexmedetomidine Administration Precipitates Respiratory Failure in Child With Croup and Asthma
ABSTRACT Intranasal dexmedetomidine administration in clinically recommended doses has a small but important risk of causing catastrophic respiratory failure in the setting of preexisting severe respiratory workloads.
Saved in:
| Main Authors: | William E. Novotny, Pam Fox, Dynita Haislip |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.9602 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment pathways and rebound-rate of prehospital viral croup attacks—data from a prehospital pediatric physician led emergency service—a prospective observational follow-up study
by: Florian Hey, et al.
Published: (2025-05-01) -
Adrenaline‐induced hypotension in the context of significant quetiapine overdose
by: Enyioma Anomelechi, et al.
Published: (2023-03-01) -
Editorial: Current trends in targeted and non-targeted metabolomics in analytical toxicology
by: Geraldine M. Dowling, et al.
Published: (2025-06-01) -
Child Sexual Abuse Module in the Child Abuse Pediatrics Curriculum for Physicians (CAP-CuP)
by: Maheen K. Bangash, et al.
Published: (2025-04-01) -
Cost savings of EMS administration of bronchodilators and systemic corticosteroids for pediatric asthma patients
by: Jennifer Fishe, et al.
Published: (2025-08-01)